BIIB - Applied Genetic Technologies: Leader Among Larger Peers In Gene Therapies For Certain Eye Diseases
- AGTC leads the pack among Biogen, JNJ and MeiraGTx in developing gene therapies for certain eye diseases.
- Cash balance is decent.
- If successful, AGTC could see some upside from these levels.
For further details see:
Applied Genetic Technologies: Leader Among Larger Peers In Gene Therapies For Certain Eye Diseases